osimertinib

proprotein convertase subtilisin/kexin type 9 ; Mus musculus







4 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34087353 Dihydroartemisinin overcomes the resistance to osimertinib in EGFR-mutant non-small-cell lung cancer. 2021 Aug 2
2 34455456 Overcoming the acquired resistance to gefitinib in lung cancer brain metastasis in vitro and in vivo. 2021 Nov 1
3 32354888 Comparison of the Efficacy of EGFR Tyrosine Kinase Inhibitors Erlotinib and Low-dose Osimertinib on a PC-9-GFP EGFR Mutant Non-small-cell Lung Cancer Growing in the Brain of Nude Mice. 2020 May-Jun 2
4 30807997 Osimertinib Regresses an EGFR-Mutant Cisplatinum- Resistant Lung Adenocarcinoma Growing in the Brain in Nude Mice. 2019 Apr 1